iTeos Therapeutics

$27.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.00 (-0.02%) As of 3:21 PM UTC today

Why Robinhood?

You can buy or sell ITOS and other stocks, options, and ETFs commission-free!

About ITOS

iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA. The listed name for ITOS is iTeos Therapeutics, Inc. Common Stock.

CEO
Michel Detheux
Employees
Headquarters
Cambridge, Massachusetts
Founded
2012
Market Cap
948.84M
Price-Earnings Ratio
Dividend Yield
Average Volume
132.13K
High Today
$27.15
Low Today
$26.79
Open Price
$27.15
Volume
1.20K
52 Week High
$34.33
52 Week Low
$17.50

Collections

ITOS Earnings

-$29.49
-$19.66
-$9.83
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 14, Pre-Market

You May Also Like